{"nct_id":"NCT03515629","title":"REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer","status":"TERMINATED","status_verified_date":"2022-10","start_date":"2018-07-02","start_date_type":"ACTUAL","primary_completion_date":"2021-07-29","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}